At the National Rx Drug Abuse & Heroin Summit, Patrice Harris, M.D., the chair-elect of the American Medical Association (AMA) and the chair of its Task Force to Reduce Opioid Abuse, detailed the AMA’s plan for ending the opioid epidemic.
AMA Address Opioids at National Summit

“The AMA’s vision for ending this epidemic starts with a focus on what physicians can do in their practices and in their communities. We not only must take responsibility for ending this epidemic, we must take action to do so, ” Dr. Harris said in the March 29, 2016 news release.
As a result of these combined efforts, Harris said:
- Physicians are participating in education targeted to their state and specialty on safe opioid prescribing;
- Physicians are prescribing naloxone—a drug that can prevent opioid overdose deaths—to at-risk patients;
- Physicians are registering with and are using their state Prescription Drug Monitoring Programs; and
- Physicians are hearing the AMA messaging that calls on physicians to be part of the solution to this epidemic.
“On behalf of the physician community, the AMA is measuring the steps physicians are taking to meet the commitments made to the administration. Harris pointed out that from 2014 to 2015, opioid prescriptions decreased 6.8 percent nationally, following a 2.9 percent decline the year before.”
“The AMA last year brought together 25 physician organizations, 17 specialty and seven state medical societies, as part of its task force on opioids. It is committed to identifying the best practices to combat this public health epidemic and to move swiftly to implement these practices across the country. AMA President Steven J. Stack, M.D., recently put out a call to action on this topic. The AMA is also working with the nation’s governors to come up with effective policy to reduce opioid overdoses.”
Dr. Harris told OTW, “The AAOS has provided considerable support for the AMA Task Force to Reduce Opioid Abuse—particularly in helping craft recommendations that encourage physicians to enhance their education and ensure safe prescribing. Leadership from physicians and their associations is crucial to ending this public health epidemic.”

Discussion
This is a fascinating development. In my practice we've seen similar outcomes with the revised protocol. The key differentiator seems to be patient selection criteria. Has anyone else noticed the correlation with BMI thresholds?
Great point. I'd push back slightly on the conclusion, the sample size in the cited study is too small to draw population-level inferences. That said, the directional signal is compelling and worth a larger RCT.
We implemented a similar approach last year. Early results are promising but we're still gathering 12-month follow-up data. Happy to share our protocol if anyone is interested.
Join the conversation
Orthopedic professionals are discussing this. Sign in and upgrade to read every comment and add your voice.